The Molecular Basis of Lymphocyte Recruitment to the Skin: Clues for Pathogenesis and Selective Therapies of Inflammatory Disorders

Journal of Investigative Dermatology

Volumn 121, Issue 5, 2003, Pages 951-962

  Schön, Michael P ^a,d   Zollner, Thomas M ^b   Boehncke, W Henning ^c  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b BAYER PHARMA AG   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALEFACEPT; ALICAFORSEN; ANTIBODY; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BIMOSIAMOSE; BIO 1211; BMS 190394; CDP 850; CELL ADHESION MOLECULE; CHEMOKINE; CY 1503; CYLEXIN; CYTOKINE; EFALIZUMAB; EFOMYCINE M; EL 246; EP 5C7; ESA 2; IC 747; IMMUNOGLOBULIN; LACTACYSTIN BETA LACTONE; LD 201T1; NATALIZUMAB; OC 229648; OJ R 9188; P SELECTIN GLYCOPROTEIN LIGAND 1; PROTEASOME INHIBITOR; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

CELL ADHESION; CELLULAR DISTRIBUTION; CIRCULATION; CLINICAL TRIAL; DERMIS; DRUG EFFECT; DRUG HALF LIFE; ENDOTHELIUM; EPIDERMIS CELL; HUMAN; INFLAMMATORY DISEASE; LYMPHOCYTE MIGRATION; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SKIN CELL; SKIN INFLAMMATION; T LYMPHOCYTE;

EID: 0242490176     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12563.x     Document Type: Review

References (170)

1. Abraham WM, Ahmed A, Sabater JR, et al: Selectin blockade prevents antigen-induced late bronchial responses and airway hyperresponsiveness in allergic sheep. Am J Respir Crit Care Med 159:1205-1214, 1999
2. Agace WW, Higgins JM, Sadasivan B, Brenner MB, Parker CM: T-lymphocyte-epithelial-cell interactions: Integrin alpha (E) (CD103) beta (7), LEEP-CAM and chemokines. Curr Opin Cell Biol 12:563-568, 2000
3. Alon R, Feigelson S: From rolling to arrest on blood vessels: Leukocyte tap dancing on endothelial integrin ligands and chemokines at sub-second contacts. Semin Immunol 14:93-104, 2002
4. Anaya-Prado R, Ramos-Kelly JR, Toledo-Pereyra LH, Walsh J, Ward PA: Multiple selectin blockade with a small-molecule selectin inhibitor does not affect survival after a second inflammatory challenge with nonlethal LPS. J Invest Surg 15:171-180, 2002
5. Anderson AO, Shaw ST: T cell adhesion to endothelium: The FRC conduit system and other anatomic and molecular features which facilitate the adhesion cascade in lymph node. Semin Immunol 5:271-282, 1993
6. Aruffo A, Hollenbaugh D: Therapeutic intervention with inhibitors of co-stimulatory pathways in autoimmune disease. Curr Opin Immunol 13:683-686, 2001
7. Asadullah K, Lowe JB, Schottelius A: Differential influences on skin inflammation models in mice deficient of alpha (1, 3)fucosyltransferase VII. Arch Dermatol Res 294:43, 2002a
8. Asadullah K, Volk HD, Sterry W: Novel immunotherapies for psoriasis. Trends Immunol 23:47-53, 2002b
9. Baekkevold ES, Yamanaka T, Palframan RT, et al: The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment. J Exp Med 193:1105-1112, 2001
10. Bank I, Rapman E, Shapiro R, et al: The epidermotropic mycosis fungoides asso7 ciated alpha1beta1 integrin (VLA-1, CD49a/CD29) is primarily a collagen IV receptor on malignant T cells. J Cutan Pathol 26:65-71, 1999
11. Bantely R, Ernst B: Synthesis of sialyl Lewis X mimetics: Modifications of the 6-position of galactose. Bioorg Med Chem Lett 11:459-462, 2001
12. Bargatze RF, Jutila MA, Butcher EC: Distinct roles of L-selectin and integrins alpha4beta7 and LFA-1 in lymphocyte homing to Peyer's patch-HEV in situ: The multistep model confirmed and refined. Immunity 3:99-108, 1995
13. Barker JNWN, Sarma V, Mitra RS, Dixit VM, Nickoloff BJ: Marked synergism between tumor necrosis factor-alpha and interferon-gamma in regulation of keratinocyte-derived adhesion molecules and chemotactic factors. J Clin Invest 85:605-608, 1990
14. Bengtson P, Lundblad A, Larson G, Pahlsson P: Polymorphonuclear leukocytes from individuals carrying the G329A mutation in the (alpha) 1,3-fucosyltransferase-VII gene (FUT7) roll on E-and P-selectins. J Immunol 169:3940-3946, 2002
15. Berg EL, Fromm C, Melrose J, Tsurushita N: Antibodies cross-reactive with E-and P-selectin block both E-and P-selectin functions. Blood 85:31-37, 1995
16. Berg EL, Yoshino T, Rott LS, et al: The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule-1. J Exp Med 174:1461-1466, 1991
17. Berlin C, Bargatze RF, Campbell JJ, et al: Alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413-422, 1995
18. Berthod F, Germain L, Li H, Xu W, Damour O, Auger FA: Collagen fibril network and elastic system remodeling in a reconstructed skin transplanted on nude mice. Matrix Biol 20:463-473, 2001
19. Bevilacqua MP, Stengelin S: Endothelial leukocyte adhesion molecule-1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160-1163, 1989
20. Bhushan M, Bleiker TO, Ballsdon AE, et al: Anti-E-selectin is ineffective in the treatment of psoriasis: A randomized trial. Br J Dermatol 146:824-831, 2002
21. Biedermann T, Schwärzler C, Lametschwandtner G, et al: Targeting CLA/E-selectin interactions prevents CCR4-mediated recruitment of human Th2 memory cells to human skin in vivo. Eur J Immunol 32:3171-3180, 2002
22. Birnbaum Y, Patterson M, Kloner RA: The effect of CY-1503, a sialyl LewisX analog blocker of the selectin adhesion molecules, on infarct size and 'no reflow' in the rabbit model of acute infarction/reperfusion. J Mol Cell Cardiol 29:2013-2025, 1997
23. Bonecchi R, Sozzani S, Stine JT, et al: Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: An amplification circuit of T helper 2 responses. Blood 92:2668-2671, 1998
24. Bonfanti R, Furie BC: PADGEM (GMP140) is a component of Waibel-Palade bodies of human endothelial cells. Blood 73:1109-1112, 1989
25. Brown DW, Furness J, Speight PM, et al: Mechanisms of binding of cutaneous lymphocyte-associated antigen-positive and alphaEbeta7-positive lymphocytes to oral and skin keratinocytes. Immunology 98:9-18, 1999
26. Butcher EC, Picker LJ: Lymphocyte homing and homeostasis. Science 272:60-66, 1996
27. Camp RL, Scheynius A, Johansson C, Pure E: CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J Exp Med 178:497-507, 1993
28. Campbell JJ, Hedrick J, Zlotnik A, Siani MA, Thompson DA: Chemokines and the arrest of lymphocytes rolling under shear flow conditions. Science 279:381-384, 1998
29. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101, 1994
30. Carraway MS, Welty-Wolf KE, Kantrow SP, et al: Antibody to E-and L-selectin does not prevent lung injury or mortality in septic baboons. Am J Respir Crit Care Med 157:938-949, 1998
31. Cepek KL, Shaw SK, Parker CM, Russell GJ, Morrow JS, Rimm DL, Brenner MB: Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alphaEbeta7 integrin. Nature 372:190-193, 1994
32. Chan JR, Hyduk SJ, Cybulski MI: Chemoattractants induce a rapid and transient upregulation of monocyte alpha4 integrin affinity for vascular cell adhesion molecule-1 which mediates arrest: An early step in the process of emigration. J Exp Med 193:1149-1158, 2001
33. Cinamon G, Grabovsky V, Winter E, et al: Novel chemokine functions in lymphocyte migration through vascular endothelium under shear flow. J Leukoc Biol 69:860-866, 2001
34. Collins RG, Jung U, Ramirez M, et al: Dermal and pulmonary inflammatory disease in E-selectin and P-selectin double-null mice is reduced in triple-selectin-null mice. Blood 98:727-735, 2001
35. Condon TP, Flournoy S, Sawyer GJ, Baker BF, Kishimoto TK, Bennett CF: ADAM17 but not ADAM10 mediates tumor necrosis factor-alpha and L-selectin shedding from leukocyte membranes. Antisense Nucl Acid Drug Dev 11:107-116, 2001
36. Constantin G, Majeed M, Giagulli C, Piccio L, Kim JY, Butcher EC, Laudanna C: Chemokines trigger immediate beta2 integrin affinity and mobility changes: Differential regulation and roles in lymphocyte arrest under flow. Immunity 13:759-769, 2000
37. Cotran RS, Gimbrone MAJ: Induction and detection of a human endothelial activation antigen in vivo. J Exp Med 164:661-666, 1986
38. da Silva AJ, Brickelmaier M, Majeau GR, Li Z, Su L, Hsu YM, Hochman PS: Alefacept, an immunomodulatory rccombinant LFA-3/IgG1 fusion protein, induces CD16 signaling and CD2/CD16-dependcnt apoptosis of CD2+ cells. J Immunol 168:4462-4471, 2002
39. de Vries IJM, Langeveld-Wildschut EG, van Reijsen FC, Bihari IC, Bruijnzeel-Koomen CAFM, Thepen T: Nonspecific T-cell homing during inflammation in atopic dermatitis: Expression of cutaneous lymphocyte-associated antigen and integrin αEβ7 on skin-infiltrating T cells. J Allergy Clin Immunol 100:694-701, 1997
40. Diacovo TG, Catalina MD, Siegelman MH, von Andrian UH: Circulating activated platelets reconstitute lymphocyte homing and immunity in L-selectin-deficient mice. J Exp Med 187:197-204, 1998
41. Diacovo TG, Puri KD, Warnock RA, Springer TA, von Andrian UH: Platelet-mediated lymphocyte delivery to high endothelial venules. Science 273:252-255, 1996
42. Dustin ML, Rothlein R, Springer T: Induction by IL-1 and interferon gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137:245-250, 1986
43. Dustin ML, Singer KH, Springer T: Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molccule-1. J Exp Med 167:1323-1340, 1988
44. Dwir O, Steeher DA, Schwarz US, Camphausen RT, Kansas GS, Tedder TF, Alon R: L-selectin dimerization enhances tether formation to properly spaced ligand. J Biol Chem 277:21130-21139, 2002
45. Ebnet K, Vestweber D: Molecular mechanisms that control leukocyte extravasation: The selectins and the chemokines. Histochem Cell Biol 112:1-23, 1999
46. Ellis CN, Krueger GG: Alefacept Clinical Study Group: Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 345:248-255, 2001
47. Feigelson SW, Grabovsky V, Winter E, et al: The Src kinase p56 (lck) up-regulates VLA-4 integrin affinity. Implications for rapid spontaneous and chemokinetriggered T cell adhesion to VCAM-1 and fibronectin. J Biol Chem 276:13891-13901, 2001
48. Feizi T: Carbohydrate ligands for the leukocyte-endothelium adhesion molecules, selectins. Results Probl Cell Differ 33:201-223, 2001
49. Ferenezi K, Fuhlbrigge RC, Pinkus J, Pinkus GS, Kupper TS: Increased CCR4 expression in cutaneous T cell lymphoma. J Invest Dermatol 119:1405-1410, 2002
50. Fitzhugh DJ, Naik S, Caughman SW, Hwang ST: Cutting edge: C-C chemokine receptor 6 is essential for arrest of a subset of memory T cells on activated dermal microvascular endothelial cells under physiologic flow conditions in vitro. J Immunol 165:6677-6681, 2000
51. Fors BP, Goodarzi K, von Andrian UH: L-selectin shedding is independent of its subsurface structures and topographic distribution. J Immunol 167:3642-3651, 2001
52. Foxman EF, Campbell J, Butcher EC: Multistep navigation and the combinatorial control of leukocyte chemotaxis. J Cell Biol 139:1349-1360, 1999
53. Fuhlbrigge RC, Kieffer JD, Armerding D, Kupper TS: Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells. Nature 389:978-981, 1997
54. Gerard C, Rollins BJ: Chemokines and disease. Nat Immunol 2:108-115, 2001
55. Girolomoni G, Sebastiani S, Albanesi C, Cavani A: T-cell subpopulations in the development of atopic and contact allergy. Curr Opin Immunol 13:733-737, 2001
56. Gniadecki K, Calverlcy MJ: Emerging drugs in psoriasis. Expert Opin Emerg Drugs 7:69-90, 2002
57. Gottlieb AB, Krueger JG, Wittkowski K, Dedrick R, Walicke PA, Garovoy M: Psoriasis as a model for T-cell-mediated disease: Immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody. Arch Dermatol 138:591-600, 2002
58. Grabbe S, Varga G, Beissert S, et al: β2 integrins are required for skin homing of primed T cells but not for priming naive T cells. J Clin Invest 109:183-192, 2002
59. Grabovsky V, Dwir O, Alon R: Endothelial chemokines destabilize L-selectin-mediated lymphocyte rolling without inducing selectin shedding. J Biol Chem 277:20640-20650, 2002
60. Grabovsky V, Feigelson S, Chen C, et al: Subsecond induction of alpha4 integrin clustering by immobilized chemokincs stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med 192:495-506, 2000
61. Griffiths CE, Railan D, Gallatin WM, Cooper KD: The ICAM-3/LFA-1 interaction is critical for epidermal Langerhans cell alloantigen presentation to CD4+ T cells. Br J Dermatol 133:823-829, 1995
62. Griffiths CEM, Voorhees JJ, Nickoloff BJ: Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: Modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol 20:617-629, 1989
63. Groves RW, Allen MH, Barker JN, Haskard DD, MacDonald DM: Endothelial leukocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol 124:117-123, 1991
64. Groves RW, Kupper TS: Leukocyte recruitment in cutaneous inflammation. In Peltz G (ed). Leukocyte Recruitment in Inflammatory Disease. New York: Springer Verlag, 1996: p 71-84
65. Groves RW, Ross EL, Barker JN, MacDonald DM: Vascular cell adhesion molccule-1 (VCAM-1). Expression in normal and diseased skin and regulation in vivo by interferon gamma. J Am Acad Dermatol 29:67-72, 1993
66. Hafezi-Moghadam A, Ley K: Relevance of L-selectin shedding for leukocyte rolling in vivo. J Exp Med 189:939-948, 1999
67. Hafezi-Moghadam A, Thomas KL, Prorock AJ, Huo Y, Ley K: L-selectin shedding regulates leukocyte recruitment. J Exp Med 193:863-872, 2001
68. He XY, Xu Z, Melrose J, et al: Humanization and pharmacokinetics of a monoclonal antibody with specificity for both E-and P-selectin. J Immunol 160:1029-1035, 1998
69. Hemler ME: VLA proteins in the integrin family: Structures, functions, and their role on leukocytes. Annu Rev Immunol 8:365-400, 1990
70. Herz U, Bunikowski R, Renz H; Role of T cells in atopic dermatitis. Int Arch Allerg Immunol 115:179-190, 1998
71. Hicke BJ, Watsou SR, Koenig A, et al: DNA aptamers block L-selectin function in vivo. 98:2688-2692, 1996
72. Homeister JW, Thall AD, Petryniak B, et al: The alpha (1,3)fucosyltransferases FucTIV and Fuc-TVII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity 15:115-126, 2001
73. Homey B, Alenius H, Müller A, et al: CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med 8:157-165, 2002
74. Homey B, Dieu-Nosjean M, Wiesenborn A, et al: Up-regulation of macrophage inflammatory protein-3α/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 164:6621-6632, 2000a
75. Homey B, Wang W, Soto H, et al: The orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol 164:3465-3470, 2000b
76. Hoogewerf AJ, Kuschert GS, Proudfoot AE, Borlat F, Clark-Lewis I, Power CA, Wells TN: Glycosyminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36:13570-13578, 1997
77. Hwang ST, Fitzhugh DJ: Aberrant expression of adhesion molecules by Sezary cells: Functional consequences under physiologic shear stress conditions. J Invest Dermatol 116:466-470, 2001
78. Hynes RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992
79. Ikegami-Kuzuhara A, Yoshinaka T, Ohmoto H, Inoue Y, Saito T: Therapeutic potential of a novel synthetic selcctin blocker, OJ-R9188, in allergic dermatitis. Br J Pharmacol 134:1498-1504, 2001
80. Issekutz AC, Issekutz TB: The role of E-selectin, P-selectin, and very late activation antigen-4 in T lymphocyte migration to dermal inflammation. J Immunol 168:1934-1939, 2002
81. Johnston B, Issekutz TB, Kubes P: The alpha4 integrin supports leukocyte rolling and adhesion in chronically inflamed postcapillary venules in vivo. J Exp Med 183:1995-2006, 1996
82. Jung U, Ley K: Mice lacking two or all three selectins demonstrate overlapping and distinct functions for each selectin. J Immunol 162:6755-6762, 1999
83. Kakinuma T, Nakamura K, Wakugawa M, et al: Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107:535-541, 2001
84. Kakinuma T, Saeki H, Tsunemi Y, et al: Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris. J Allergy Clin Immunol 111:592-597, 2003
85. Karecla PI, Bowden SJ, Green SJ, Kilshaw PJ: Recognition of E-cadherin on epithelial cells by the mucosal T cell integrin alphaM290beta7 (alphaEbeta7). Eur J Immunol 25:852-856, 1995
86. Kashihara-Sawami M, Norris DA: The state of differentiation of cultured human keratinocytes determines the level of intercellular adhesion molecule-1 (ICAM-1) expression induced by gamma interferon. J Invest Dermatol 98:852-856, 1992
87. Kerr KM, Auger WR, Marsh JJ, et al: The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. Am J Respir Crit Care Med 162:14-20, 2000
88. Khor SP, McCarthy K, DuPont M, Murray K, Timony G: Pharmacokinetics, pharmacodynamics, allometry, and dose selection of rPSGL-Ig for phase I trial. J Pharmacol Exp Ther 293:618-624, 2000
89. Knowles DM, Halper JP: Human T-cell malignancies: Correlative clinical, histopathologic, immunologic, and cytochemical analysis of 23 cases. Am J Pathol 106:187-196, 1982
90. Konter U, Kellner I, Sterry W: Adhesion molecule mapping in normal human skin. Arch Dermatol Res 281:454-462, 1989
91. Krueger GG, Papp KA, Stough DB, Loven KH, Gulliver WP, Ellis CN: Alefacept Clinical Study Group: A randomized, double-blind, placebo-controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasis. J Am Acad Dermatol 47:821-833, 2002
92. Krueger JG, Wolfe JT, Nabeya RT, et al: Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells. J Exp Med 182:2057-2068, 1995
93. Kunkel EJ, Boisvert J, Murphy K, et al: Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am J Pathol 160:347-355, 2002
94. Kunkel EJ, Butcher EC: Chemokines and the tissue-specific migration of lymphocytes. Immunity 16:1-4, 2002
95. Kunstfeld R, Lechleitner S, Groger M, Wolff K, Petzelbauer P: HECA-452+ T cells migrate through superficial vascular plexus but not through deep vascular plexus endothelium. J Invest Dermatol 108:343-348, 1997
96. Kuschert GS, Coulin F, Power CA, Proudfoot AE, Hubbard RE, Hoogwerf AJ, Wells TN: Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38:12959-12968, 1999
97. Labow MA, Norton CR, Rumberger JM, et al: Characterization of E-selectin-deficient mice: Demonstration of overlapping function of the endothelial selectins. Immunity 1:709-720, 1994
98. Lechleitner S, Kunstfeld R, Messeritsch-Fanta C, Wolff K, Petzelbauer P: Peripheral lymph node addressins are expressed on skin endothelial cells. J Invest Dermatol 113:410-414, 1999
99. Leonard WJ: TSLP: Finally in the limelight. Nat Immunol 3:605-607, 2002
100. Ley K: Functions of selecting. Results Probl Cell Differ 33:177-200, 2001
101. Lowe JB: Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney Int 51:1418-1426, 1997
102. Lub M, van Kooyk Y, van Vliet SJ, Figdor CG: Dual role of the actin cytoskeleton in regulating cell adhesion mediated by the integrin lymphocyte function-associated molccule-1. Mol Biol Cell 8:341-351, 1997
103. Ludwig RJ, Schultz JE, Weber C, Kaufmann R, Podda M, Zollner TM: Platelet activation in psoriasis: A possible link to inflammation? J Invest Dermatol 117:766, 2001
104. Mackay CR: Chemokines: Immunology's high impact factors. Nat Immunol 2:95-101, 2001
105. Mackay CR: New avenues for anti-inflamatory therapy. Nat Med 8:117-118, 2002
106. Maksymowych WP, Blackburn WDJ, Tami JA, Shanahan WRJ: A randomized, placebo-controlled trial of an antisense oligodeoxynucleotide to intercellular adhesion molecule-1 in the treatment of severe rheumatoid arthritis. J Rheumatol 29:447-453, 2002
107. Maly P, Thall A, Petryniak B, et al: The alpha (1, 3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, .E-, and P-selectin biosynthesis. Cell 86:643-653, 1996
108. Marinier A, Martel A, Bachand C, et al: Novel mimics ot sialyl Lewis X: Design, synthesis and biological activity in a series of 2-and 3-malonate substituted galactoconjugates. Bioorg Med Chem 9:1395-1427, 2001
109. McEver RP, Beckstead JH: GMP-140, a platelet alpha granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Waibel-Palade bodies. J Clin Invest 84:92-99, 1989
110. Middleton J, Neil S, Wintle J, et al: Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell 91:385-395, 1997
111. Nickoloff BJ: Role of interferon-gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events. Arch Dermatol 124:1835-1845, 1988
112. Olivry T, Moore PF, Naydan DK, Danilenko DM, Affolter VK: Investigation of epidermotropism in canine mycosis fungoides: Expression of intercellular adhesion molecule-1 (ICAM-1) and beta-2 integrins. Arch Dermatol Res 287:186-192, 1995
113. Olsen TS, Ley K: Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Reg Integrative Comp Physiol 283:7-28, 2002
114. Onuffer JJ, Horuk R: Chemokines, chemokine receptors and small-molecule antagonists: Recent developments. Trends Pharmacol Sci 23:459-467, 2002
115. Owen C: Chemokine receptors in airway disease: Which receptors to target? Pulm Pharmacol Ther 14:193-202, 2001
116. Papp K, Bissonnette R, Krueger JG, et al: The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody. J Am Acad Dermatol 45:665-674, 2001
117. Parker CM, Cepek KL, Russell GJ, Shaw SK, Posnett DN, Schwarting R, Brenner MB: A family of beta 7 integrins on human mucosal lymphocytes. Proc Natl Acad Sci USA 89:1924-1929, 1992
118. Pauls K, Schön M, Kubitza RC, et al: Role of integrin αE (CD103) β7 for tissue-specific epidermal localization of CD8+ T lymphocytes. J Invest Dermatol 117:569-575, 2001
119. Petzelbauer P, Pober JS, Keh A, Braverman IM: Inducibility and expression of microvascular endothelial adhesion molecules in lesional, perilesional, and uninvolved skin of psoriatic patients. J Invest Dermatol 103:300-305, 1994
120. Picker LJ, Kishimoto TK, Smith CW, Warnock RA, Butcher EC: ELAM-1 is an adhesion molecule for skin-homing T-cells. Nature 349:796-799, 1991
121. Picker LJ, Michie SA, Rott LS, Butcher EC: A unique phenotype of skin-associated lymphocytes in humans: Preferential expression of the HECA-425 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 136:1053-1068, 1990
122. Proudfoot AE, Fritchley S, Borlat F, et al: The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J Biol Chem 276:10620-10626, 2001
123. Reinhardt PH, Elliott JF, Kubes P: Neutrophils can adhere via alpha4beta1-integrin under flow conditions. Blood 89:3837-3846, 1997
124. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC: CC chemokine receptor (CCR) 4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 194: 1541-1547, 2001
125. Robert C, Kupper TS: Inflammatory skin diseases, T cells, and immune surveillance. N Engl J Med 341:1817-1828, 1999
126. Robertson D: Crohns trial shows the pros of antisense. Nat Biotechnol 15:209, 1997
127. Rossiter H, van Reijsen F, Mudde GC, Kalthoff F, Bruijnzeel-Koomen CAFM, Picker LJ, Kupper TS: Skin disease-related T cells bind to endothelial selectins: Expression of cutaneous lymphocyte antigen (CLA) predicts E-selectin but not P-selectin binding. Eur J Immunol 24:205-210, 1994
128. Rottman JB, Smith TL, Ganley KG, Kikuchi T, Krueger JG: Potential role of the chemokine receptors CXCR3, CCR4, and the integrin aEb7 in the pathogenesis of psoriasis vulgaris. Lab Invest 81:335-347, 2001
129. Sanchez-Madrid F, del Pozo MA: Leukocyte polarization in cell migration and immune interaction. EMBO J 18:501-511, 1999
130. Santamaria Babi LF, Moser R, Perez Soler MT, Picker LJ, Blaser K, Hauser C: Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J Immunol 154:1543-1550, 1995
131. Schechner JS, Edelson RL, McNiff JM, Heald PW, Pober JS: Integrins alpha4beta7 and alphaEbeta7 are expressed on epidermotropic T cells in cutaneous T cell lymphoma and spongiotic dermatitis. Lab Invest 79:601-607, 1999
132. Schön MP: Animal models of psoriasis - what can we learn from them? J Invest Dermatol 112:405-410, 1999
133. E (CD103) deficient mice. J Immunol 162: 6641-6649, 1999
134. Schön MP, Krahn T, Schön M, et al: Efomycine M, a new specific inhibitor of selectin, impairs leukocyte adhesion and alleviates cutaneous inflammation. Nat Med 8:366-372, 2002
135. Schön MP, Ruzicka T: Psoriasis: The plot thickens.... Nat Immunol 2:91, 2001
136. Shand A, Forbes A: Potential therapeutic role for cytokine or adhesion molecule manipulation in Crohn's disease, in the shadow of infliximab? Int J Coloreftal Dis 18:1-11, 2003
137. Shieh CC, Sadasivan BK, Russell GJ, Schön MP, Parker CM, Brenner MB: Lymphocyte adhesion to epithelia and eudothelia mediated by the LEEP-CAM glycoprotein. J Immunol 163:1592-1601, 1999
138. Shimizu Y, Newman W, Gopal TV, et al: Four molecular pathways of T cell adhesion to endothelial cells: Roles of LFA-1, VCAM-1, and ELAM-1 and changes in pathway hierarchy under different activation conditions. J Cell Biol 113: 1203-1212, 1991
139. Shimizu Y, Rose DM, Ginsberg MH: Integrins in the immune system. Adv Immunol 72:325-380, 1999
140. Shinkai A, Shinoda K, Sasaki K, et al: High-level expression and purification of a recombinant human alpha (1,3)fucosyltramferase in baculovirus-infected insect cells. Protein Expr Purif 10:379-385, 1997
141. Shinoda K, Shitara K, Yoshihara Y, et al: Panosialins, inhibitors of an alpha 1.3 fucosyltransrerase Fuc-VII, suppress the expression of selectin ligands on U937 cells. Glycoconj J 15:1079-1083, 1998
142. Simonitsch I, Volc-Platzer B, Mosberger I, Radaszkiewicz T: Expression of monoclonal antibody defined αEβ7 integrin in cutaneous T cell lymphoma. Am J Pathol 145:1148-1158, 1994
143. Singbartl K, Thatte J, Smith ML, Wethmar K, Day K, Ley K: A CD2-green fluorescence protein-transgenic mouse reveals very late antigen-4-dependent CD8+ lymphocyte rolling in inflamed venules. J Immunol 166:7520-7526, 2001
144. Smith CH, Barker JNWN, Morris RW, MacDonald DM, Lee TH: Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 151:3274-3282, 1993
145. Smithers N, Kelly VA, Witham SJ, Edbrooke MR, Britten CJ: Expression of a secreted form of human alpha (1,3) fucosyltransferase VII from insect cells. Biochem Soc Trans 25:426, 1997
146. Smithson G, Rogers CE, Smith PL, et al: Fuc-TVII is required for T helper 1 and T cytotoxic 1 lymphocyte selectin ligand expression and recruitment in inflammation, and together with Fuc-TIV regulates naive T cell trafficking to lymph nodes. J Exp Med 194:601-614, 2001
147. Soler D, Humphreys TL, Spinola SM, Campbell JJ: CCR4 versus CCR10 in human cutaneous TH lymphocyte trafficking. Blood 101:1677-82, 2002
148. Soumelis V, Reche PA, Kanzler H, et al: Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3:673-680, 2002
149. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm. Cell 76:301-314, 1994
150. Sterry W, Mielke V, Konter U, Kellner I, Boehncke WH: Role of β1 integrins in epidermotropism of malignant T cells. Am J Pathol 141:855-860, 1992
151. Strauch UG, Mueller RC, Li XY, Cernadas M, Higgins JMC, Binion DG, Parker CM: Integrin αE (CD103) β7 mediates adhesion to intestinal microvascular endothelial cell lines via an E-cadherin-independent interaction. J Immunol 166:3506-3514, 2001
152. Syrbe U, Siveke J, Hamann A: Th1/Th2 subset: Distinct differences in homing and chemokine expression? Springer Semin Immunopathol 21:263-285, 1999
153. Takagi J, Erickson HP, Springer TA: C-terminal opening mimicks 'inside-out' activation of integrin alpha5beta1. Nat Struct Biol 8:412-416, 2001
154. Thoma G, Magnani JL, Patton JT: Synthesis and biological evaluation of a sialyl LewisX mimic with significantly improved E-selectin inhibition. Bioorg Med Chem Lett 11:923-925, 2001
155. Thomson AW, Nalesnik MA, Rilo HR, Woo J, Carroll PB, van Thiel DH: ICAM-1 and E-selectin expression in lesional biopsies of psoriasis patients responding to systemic FK 506 therapy. Autoimmunity 15:215-223, 1993
156. Ticchioni M, Raimondi V, Lamy L, Wijdens J, Lindberg FP, Brown EJ, Bernard A: Integrin-associated protein (CD47/IAP) contributes to T cell arrest in inflammatory vascular endothelium under shear flow. FASEB J 15:341-350, 2001
157. Todderud G, Nair X, Lee D, et al: BMS-190394, a selectin inhibitor, prevents rat cutaneous inflammatory reactions. J Pharmacol Exp Ther 282:1298-1304, 1997
158. Varki A: Selectin ligands. Proc Natl Acad Sci USA 91:7390-7397, 1994
159. von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC: Two-step model of leukocyte-endothelial cell interaction in inflammation: Distinct roles for LECAM-1 and the leukocyte beta-2 integrins in vivo. Proc Natl Acad Sci U S A 88:7538-7542, 1991
160. Wagner LA, Brown T, Gil S, Frank I, Carter W, Tamura R, Wayner EA: The keratinocyte-derived cytokine IL-7 increases adhesion of the epidermal T cell subset to the skin basement membrane protein laminin-5. Eur J Immunol 29: 2530-2538, 1999
161. Walton LJ, Thornhill MH, Macey MG, Farthing PM: Cutaneous lymphocyte associated antigen (CLA) and αEβ7 integrins are expressed by mononuclear cells in skin and oral lichen pianus. J Oral Pathol Med 26:402-407, 1997
162. Wayner EA, Gil SG, Murphy GF, Wilke MS, Carter WG: Epiligrin, a component of epithelial basement membranes, is an adhesive ligand for α3β1 positive T lymphocytes. J Cell Biol 121:1141-1152, 1993
163. Weninger W, Ulfman LH, Cheng G, Souchkova N, Quackenbush EJ, Lowe JB, von Andrian UH: Specialized contributions by alpha (1,3)fucosyltransferase-IV and Fuc-TVII during leukocyte rolling in dermal microvessels. Immunity 12: 665-676, 2000
164. Williams IR, Kupper TS: Epidermal expression of intercellular adhesion molecule-1 is not a primary inducer of cutaneous inflammation in transgenic mice. Proc Natl Acad Sci USA 91:9710-9714, 1994
165. Yacyshyn BR, Chey WY, Goff J, et al: Double-blind, placebo-controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease. Gut 51:30-36, 2002
166. Yauch RL, Felsenfeld DP, Kraeft SK, Chen LB, Sheetz MP, Hemler ME: Mutational evidence for control of cell adhesion through integral recruitment, independent of ligand binding. J Exp Med 186:1-9, 1997
167. Yu B, Koga T, Urabe K, Moroi Y, Maeda S, Yanagihara Y, Furue M: Differential regulation of thymus-and activation-regulated chemokine induced by IL-4, IL-13, TNF-alpha and IFN-gamma in human keratinocytes and fibroblasts. J Dermatol Sci 30:29-35, 2002
168. Zhao LC, Edgar JB, Dailey MO: Characterization of the rapid proteolytic shedding of murine L-selectin. Dev Immunol 8:267-277, 2001
169. Zlotnik A, Yoshie O: Chemokines. A new classification system and their role in immunity. Immunity 12:121-127, 2000
170. Zollner TM, Podda M, Pien C, Elliott PJ, Kaufmann R, Boehncke WH: Proteasome inhibition reduces superantigen-mediatcd T cell activation and the severity of psoriasis in a SCID-hu model. J Clin Invest 109:671-679, 2002